# Techprecision Corp: Form 10-Q for the period ended Sep 30, 2023

- Company: [Techprecision Corp](/companies/tpcs.md) (CIK 1328792)
- Form: 10-Q
- Filed: 2023-11-20
- Accepted by EDGAR: Nov 20, 2023, 16:41 ET
- Period: 2023-09-30
- Accession: 0001410578-23-002556
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1328792/000141057823002556/tpcs-20230930x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1328792/000141057823002556/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2023-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2023-07-01 to 2023-09-30 | $8.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months, 2023-04-01 to 2023-09-30 | $15.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Gross profit | 3 months, 2023-07-01 to 2023-09-30 | $1.0m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2023-04-01 to 2023-09-30 | $1.7m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2023-07-01 to 2023-09-30 | $1.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2023-04-01 to 2023-09-30 | $2.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2023-07-01 to 2023-09-30 | −$597.4k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2023-04-01 to 2023-09-30 | −$1.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2023-07-01 to 2023-09-30 | $148.6k | us-gaap:InterestExpense |
| Interest expense | 6 months, 2023-04-01 to 2023-09-30 | $242.6k | us-gaap:InterestExpense |
| Income tax | 3 months, 2023-07-01 to 2023-09-30 | −$176.7k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2023-04-01 to 2023-09-30 | −$323.1k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2023-07-01 to 2023-09-30 | −$528.3k | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2023-04-01 to 2023-09-30 | −$1.1m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months, 2023-07-01 to 2023-09-30 | −$0.06 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2023-04-01 to 2023-09-30 | −$0.12 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2023-07-01 to 2023-09-30 | −$0.06 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2023-04-01 to 2023-09-30 | −$0.12 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2023-07-01 to 2023-09-30 | 8,720,603 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2023-04-01 to 2023-09-30 | 8,667,298 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2023-04-01 to 2023-09-30 | $1.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2023-04-01 to 2023-09-30 | $2.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2023-09-30 | $138.2k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2023-09-30 | $14.5m | us-gaap:AssetsCurrent |
| Total assets | at 2023-09-30 | $38.0m | us-gaap:Assets |
| Current liabilities | at 2023-09-30 | $15.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2023-09-30 | $24.5m | us-gaap:Liabilities |
| Shareholders' equity | at 2023-09-30 | $13.5m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 53,686 characters.

### Statement Regarding Forward Looking Disclosure

The following discussion of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and the related notes, which appear elsewhere in this Quarterly Report on Form 10-Q. This Quarterly Report on Form 10-Q, including this section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” may contain predictive or “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of current or historical fact contained in this quarterly report, including statements that express our intentions, plans, objectives, beliefs, expectations, strategies, predictions, or any other statements relating to our future activities or other future events, or conditions are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “will,” “should,” “would” and similar expressions, as they relate to us, are intended to identify forward-looking statements.

These forward-looking statements are based on current expectations, estimates and projections made by management about our business, our industry and other conditions affecting our financial condition, results of operations or business prospects. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in, or implied by, the forward-looking statements due to numerous risks and uncertainties. Factors that could cause such outcomes and results to differ include, but are not limited to, risks and uncertainties arising from:

- our reliance on individual purchase orders, rather than long-term contracts, to generate revenue;
- our ability to balance the composition of our revenues and effectively control operating expenses;
- external factors that may be outside our control: including health emergencies, like epidemics or pandemics, the conflicts in Eastern Europe and the Middle East, price inflation, interest rates increases, and supply chain inefficiencies;
- the availability of appropriate financing facilities impacting our operations, financial condition and/or liquidity;
- our ability to receive contract awards through competitive bidding processes;
- our ability to maintain standards to enable us to manufacture products to exacting specifications;
- our ability to enter new markets for our services;
- our reliance on a small number of customers for a significant percentage of our business;
- competitive pressures in the markets we serve;
- changes in the availability or cost of raw materials and energy for our production facilities;
- restrictions in our ability to operate our business due to our outstanding indebtedness;
- government regulations and requirements;
- pricing and business development difficulties;
- changes in government spending on national defense;
- our ability to make acquisitions and successfully integrate those acquisitions with our business;
- our failure to maintain effective internal controls over financial reporting;
- general industry and market conditions and growth rates, and
- those risks discussed in “*Item 1A. Risk Factors”* and elsewhere in our Annual Report on Form 10-K, as well as those described in any other filings which we make with the SEC.

Any forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to publicly update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this Quarterly Report on Form 10-Q, except as required by applicable law. Investors should evaluate any statements made by us in light of these important factors.

### Overview

#### Contract Manufacturing

Through our two wholly owned subsidiaries, Ranor and Stadco, each of which is a reportable segment, we offer a full range of services required to transform raw materials into precision finished products. Our manufacturing capabilities include fabrication operations (cutting, press and roll forming, assembly, welding, heat treating, testing, and finishing) and machining operations including CNC (computer numerical controlled) horizontal and vertical machining centers. We also provide support services to our manufacturing capabilities: manufacturing engineering (planning, fixture and tooling development, manufacturing), CNC programming, materials procurement, quality control (material traceability, material receipt inspection, NDT (non-destructive testing) dimensional inspection, and document control), production control (scheduling and project management) and final packaging.

All manufacturing is done in accordance with our quality assurance programs, in conjunction with customer flow-downs and specifications. The customer flow-downs of specifications and standards are specific to each customer purchase order, and our manufacturing operations are conducted in accordance with each specific purchase order.

Because our revenues are derived from the sale of goods manufactured pursuant to contracts, and we do not sell from inventory, it is necessary for us to constantly seek new contracts. There may be a time lag between our completion of one contract and commencement of work on another contract. During such periods, we may continue to incur overhead expense but with lower revenue resulting in lower operating margins. Furthermore, changes in either the scope of an existing contract or related delivery schedules may impact the revenue we receive under the contract and the allocation of manpower. Although we provide manufacturing services for large governmental programs, we usually do not work directly for the government or its agencies. Rather, we perform our services for large governmental contractors. Our business is dependent in part on the continuation of government programs that require our services and products.

Our contracts are generated both through negotiation with the customer and from bids made pursuant to a request for proposal. Our ability to receive contract awards is dependent upon the contracting party’s perception of such factors as our ability to perform on time, our history of performance, including quality, our financial condition, and our ability to price our services competitively. Although some of our contracts contemplate the manufacture of one or a limited number of units, we continue to seek more long-term projects with predictable cost structures.

All the Company’s operations, assets, and customers are located in the U.S.

#### Critical Accounting Policies and Estimates

The preparation of the condensed consolidated financial statements requires that we make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We base our estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We continually evaluate our estimates, including those related to revenue recognition and income taxes. These estimates and assumptions require management’s most difficult, subjective or complex judgments. Actual results may vary under different assumptions or conditions.

We consider the principles and estimates applied for revenue recognition to be one of the most critical accounting estimates that we make. Our revenue can fluctuate from quarter-to-quarter as we measure revenue recognition over the duration of a project, or at the end of the project. The Company records most of its revenue over time as it completes performance obligations or at a point-in-time, for example, at the delivery date, when control of the promised goods are transferred to the customer. Project volume for revenue recognized at a point-in-time is generally smaller, can fluctuate from period to period, and is difficult to forecast.

We measure progress for performance obligations satisfied over time using input methods, for example, labor hours expended and time elapsed. As a result, assuming a steady flow of project volume and labor hours, we have the ability to deliver a fair and accurate flow of revenue over time. When project volume is higher or lower, we may report higher or lower amounts of revenue for those given quarterly periods.

Our significant accounting policies are set forth in detail in Note 2 to the consolidated financial statements included in the 2023 Annual Report on Form 10-K. There were no significant changes to our critical accounting policies during the six months ended September 30, 2023.

#### New Accounting Standards

See Note 2, *Basis of Presentation and Significant Accounting Policies*, in the Notes to the Unaudited Condensed Consolidated Financial Statements under “*Item 1. Financial Statements”*, for a discussion of recently adopted new accounting guidance.

### Results of Operations

Our results of operations are affected by a number of external factors including the availability of customer furnished material, raw materials, commodity prices (particularly steel), macroeconomic factors, including the availability of capital that may be needed by our customers, and political, regulatory and legal conditions in the United States and in foreign markets. It generally takes approximately twelve months or less to complete our manufacturing projects. However, contracts for larger complex components can take up to thirty-six months or more to complete. Units manufactured under the majority of our customer contracts have historically been delivered on time and with a positive gross margin, with some exceptions. Our results of operations are also affected by our success in booking new contracts, the timing of revenue recognition, delays in customer acceptances of our products, delays in deliveries of ordered products and our rate of progress fulfilling obligations under our contracts. A delay in deliveries or cancellations of orders could have an unfavorable impact on liquidity, cause us to have inventories in excess of our short-term needs, and delay our ability to recognize, or prevent us from recognizing, revenue on contracts in our order backlog.

We evaluate the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that we consider not representative of ongoing operations, such as refundable employee retention tax credits.

#### Key Performance Indicators

While we prepare our financial statements in accordance with U.S. generally accepted accounting principles, or “U.S. GAAP”, we also utilize and present certain financial measures that are not based on or included in U.S. GAAP. We refer to these as non-GAAP financial measures. Please see the section titled “*EBITDA Non-GAAP financial measure”* below for further discussion of these financial measures, including the reasons why we use such financial measures and reconciliations of such financial measures to the most directly comparable U.S. GAAP financial measures.

Percentages in the following tables and throughout this “*Results of Operations”* section may reflect rounding adjustments. Prior period segment data is revised to reflect new allocations. Prior period Selling, General and Administrative, or “SG&A”, segment data is revised to reflect current period updates to unallocated corporate administrative expense.

### Three Months Ended September 30, 2023 and 2022

The following table presents net sales, cost of sales and gross profit, consolidated and by reportable segment:

*(dollars in thousands)*

| ​ ​ ​ Net sales | ​ ​ ​ ​ | ​ ​ September 30, 2023 ​ Amount ​ ​ | ​ ​ ​ | ​ ​ Percent of ​ Net sales ​ ​ ​ | ​ ​ September 30, 2022 ​ Amount ​ ​ | ​ ​ ​ | ​ ​ Percent of ​ Net sales ​ ​ ​ | ​ ​ Changes ​ Amount ​ ​ | ​ ​ ​ | ​ ​ ​ ​ Percent ​ ​ |
| --- | --- | ---: | --- | ---: | ---: | --- | ---: | ---: | --- | ---: |
| Ranor | ​ | $4,495 |  | 55% | $4,934 |  | 58% | $(439) |  | (9)% |
| Stadco | ​ | ​ 3,606 |  | 45% | ​ 3,589 |  | 42% | ​ 17 |  | 1% |
| Intersegment elimination | ​ | ​ (131) |  | —% | ​ — |  | —% | ​ (131) |  | nm% |
| Consolidated Net sales | ​ | $7,970 |  | 100% | $8,523 |  | 100% | $(553) |  | (6)% |
| **Cost of sales** | ​ | ​ ​ | ​ | ​ ​ | ​ ​ | ​ | ​ ​ | ​ ​ | ​ | ​ ​ |
| Ranor | ​ | $3,320 |  | 42% | $2,907 |  | 34% | $413 |  | 14% |
| Stadco | ​ | ​ 3,615 |  | 45% | ​ 3,876 |  | 46% | ​ (261) |  | (7)% |
| Consolidated Cost of sales | ​ | $6,935 |  | 87% | $6,783 |  | 80% | $152 |  | 2% |
| **Gross profit (loss)** | ​ | ​ ​ | ​ | ​ ​ | ​ ​ | ​ | ​ ​ | ​ ​ | ​ | ​ ​ |
| Ranor | ​ | $1,044 | ​ | 13% | $2,027 | ​ | 23% | $(983) | ​ | (48)% |
| Stadco | ​ | ​ (9) | ​ | —% | ​ (287) | ​ | (3)% | ​ 278 | ​ | 97% |
| Consolidated Gross profit | ​ | $1,035 | ​ | 13% | $1,740 | ​ | 20% | $(705) | ​ | (41)% |

#### nm - not meaningful

### Net Sales

*Consolidated* - Period-to-period revenues reflect production performance under new and ongoing contracts with changes in net sales due to varying production activity levels. For the second quarter, almost 100% of our sales were to the defense sector, where we have customers in the aerospace, military and shipbuilding industries.

Consolidated net sales were $8.0 million for the three months ended September 30, 2023, or 6% lower when compared to net sales of $8.5 million for the three months ended September 30, 2022. Both segments logged a different mix of products, average price, and labor hours for the comparable periods. Net sales decreased by $0.4 million at Ranor and decreased by $0.1 million at Stadco. The defense backlog remains strong as new orders for components related to a variety of programs, including the U.S. Navy submarine programs, and the U.S. Marine Corps heavy lift helicopter programs continue to flow down from our existing customer base of prime defense contractors.

*Ranor –* Net sales were $4.5 million for the three months ended September 30, 2023, a decrease of $0.4 million or 9% when compared to the same period in the prior year. All the net sales in the second quarter of fiscal 2024 were in the defense sector. The second quarter of fiscal 2024 had a different mix of products for U.S. Navy submarine projects, and experienced supply chain impacts on customer furnished material. We recorded a $0.7 million decrease when compared to the same period last year. That decrease was offset in part by a revenue increase of $0.3 million from a non-submarine customer.

*Stadco -* Net sales were $3.5 million for the three months ended September 30, 2023, a decrease of $114,000 when compared to the three months ended September 30, 2022. An increase in net sales for heavy lift helicopter and military products of $1.0 million was more than offset by a decrease of $1.1 million with other customers.

### Cost of Sales and Gross Profit

*Consolidated –* Cost of sales consists primarily of raw materials, parts, labor, overhead and subcontracting costs. Our cost of sales for the three months ended September 30, 2023, was $6.9 million, or 2% higher when compared to the three months ended September 30, 2022. The increase in cost of sales was primarily the result of a less favorable project mix at Ranor, offset in part by better throughput at Stadco. Gross profit decreased by $0.7 million, or 41% when compared to the same period a year ago. Gross margin for the three months ended September 30, 2023 was 13.0% compared to 20.4% in the same period a year ago.

*Ranor –* Gross profit decreased by $1.0 million or 48% due primarily to lower revenue and a less favorable project mix with lower gross margins than the same prior year period. We realized fewer direct labor hours of input for the three months ended September 30, 2023 due to employee turnover and training. As a result, overhead was under-absorbed as the amount applied to our work-in-progress was less than the overhead applied for the three months ended September 30, 2022.

*Stadco –* Gross profit and gross margin were relatively improved for the three months ended September 30, 2023 as losses decreased when compared to the three months ended September 30, 2022. Stadco improved year over year with better margins on projects, partially offset by an increase in under-absorbed factory overhead. With revenue growth, we should see improvement in gross profit and gross margin in future quarters.

### Selling, General and Administrative (SG&A) Expenses

*(dollars in thousands)*

| ​ ​ ​ | ​ ​ ​ | ​ ​ September 30, 2023 ​ ​ Amount | ​ ​ | ​ ​ ​ Percent of ​ Net Sales | ​ ​ September 30, 2022 ​ ​ Amount | ​ ​ | ​ ​ ​ Percent of ​ Net Sales | ​ ​ Changes ​ ​ Amount | ​ ​ | ​ ​ ​ ​ Percent |
| --- | --- | ---: | --- | ---: | ---: | --- | ---: | ---: | --- | ---: |
| Ranor | ​ | $371 | ​ | 5% | $471 | ​ | 6% | $(100) | ​ | (21)% |
| Stadco | ​ | ​ 314 | ​ | 4% | ​ 468 | ​ | 5% | ​ (154) | ​ | (33)% |
| Corporate and unallocated | ​ | ​ 947 | ​ | 12% | ​ 888 | ​ | 10% | ​ 59 | ​ | 7% |
| Consolidated SG&A | ​ | $1,632 | ​ | 21% | $1,827 | ​ | 21% | $(195) | ​ | (11)% |

*September 30, 2022 SG&A segment data is revised to reflect current period updates to unallocated corporate administrative expense.*

*Consolidated –* Total selling, general and administrative expenses for the three months ended September 30, 2023, decreased by approximately $195,000, or 11%, but remained level as a percentage of net sales. Ranor and Stadco expense decreased but was partially offset by higher corporate expenses for outside advisory services.

*Ranor –* The total change for the comparable three-month periods equaled the sum of a decrease in compensation and payroll taxes of approximately $11,000 plus a decrease in outside advisory fees and office costs of $89,000. The prior year three-month period includes a one-time fee for services rendered in connection with securing the Employee Retention Tax Credit refund.

*Stadco –* SG&A expense for the three months ended September 30, 2023 decreased by approximately $154,000. Expenses for compensation and office costs decreased by approximately $128,000 due to staff reductions plus a decrease in outside advisory services of approximately $26,000.

*Corporate and unallocated –* SG&A increased by approximately $59,000, due primarily to the increased expenditures for outside advisory services, which more than offset a reduction in stock-based compensation.

### Operating loss

*(dollars in thousands)*

| ​ ​ ​ | ​ ​ ​ | ​ ​ September 30, 2023 ​ ​ Amount | ​ ​ | ​ ​ Percent of net sales ​ | ​ ​ September 30, 2022 ​ ​ Amount | ​ ​ | ​ ​ Percent of ​ net sales ​ | ​ ​ Changes ​ ​ Amount | ​ ​ | ​ ​ ​ ​ ​ Percent ​ |
| --- | --- | ---: | --- | ---: | ---: | --- | ---: | ---: | --- | ---: |
| Ranor | ​ | $673 | ​ | 8% | $1,556 | ​ | 18% | $(883) | ​ | (57)% |
| Stadco |  | ​ (323) |  | (4)% | ​ (755) |  | (9)% | ​ 432 |  | 57% |
| Corporate and unallocated |  | ​ (947) |  | (12)% | ​ (888) |  | (10)% | ​ (59) |  | (7)% |
| Operating loss | ​ | $(597) |  | (8)% | $(87) |  | (1)% | $(510) |  | (586)% |

*Consolidated –* As a result of the foregoing, for the three months ended September 30, 2023, we reported an operating loss of $0.6 million. Operating income at Ranor was not enough to offset the operating loss at Stadco and corporate and unallocated expenses.

*Ranor –* Operating income was lower when compared to the same period a year ago, due primarily to a less favorable project mix with lower revenue and higher cost of sales, as described above.

*Stadco –* Operating losses narrowed as certain production problems, including equipment downtime, were resolved. Despite the better throughput, we recorded an operating loss as revenue was flat year-over-year.

*Corporate and unallocated –* Operating loss reflected SG&A expense which increased by approximately $59,000, due primarily to the increased expenditures for outside advisory services, which more than offset a reduction in stock-based compensation.

### Other Income (Expense), net

The following table presents other income (expense) for the three months ended:

| ​ ​ | ​ | ​ ​ September 30, 2023 | ​ | ​ ​ September 30, 2022 | ​ | ​ ​ $ Change | ​ ​ ​ % Change |
| --- | --- | ---: | --- | ---: | --- | ---: | ---: |
| Other income (expense), net | ​ | $40,875 | ​ | $73,561 | ​ | $(32,686) | (44)% |
| Interest expense | ​ | $(129,839) | ​ | $(70,382) | ​ | $(40,543) | (58)% |
| Amortization of debt issue costs | ​ | $(18,714) | ​ | $(13,348) | ​ | $(5,366) | (40)% |

Interest expense was higher when compared with the three months ended September 30, 2022. Interest expense increased year over year primarily due to higher interest rates and higher borrowings under the Revolver Loan (as defined below) and lower amounts of interest capitalized. We expect any future interest expense increases will correlate directly with the borrowing levels under the Revolver Loan.

Amortization of debt issue costs, for the three months ended September 30, 2023, were higher when compared to three months ended September 30, 2022. New amortization periods commenced in December 2022 for costs incurred to extend the Ranor Term Loan and renew the Revolver Loan.

Other income, net for the three months ended September 30, 2023 includes a gain from the disposal of fixed assets. Other income, net, for the three months ended September 30, 2022, includes income from the net change in fair value for contingent consideration of $96,909 plus other tax rebates for $33,223, offset in part by the fair value of the stock issued for $56,310 in connection with the Stadco acquisition.

### Income Taxes

For the three months ended September 30, 2023, the Company recorded a tax benefit $176,698, compared with tax expense of $135,509 for the three months ended September 30, 2022.

Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences and carryforwards are expected to be recovered or settled. The valuation allowance on deferred tax assets at September 30, 2023 was approximately $2.1 million. We believe that it is more likely than not that the benefit from certain state NOL carryforwards and other deferred tax assets will not be realized. In recognition of this risk, we continue to provide a valuation allowance on these items. In the event future taxable income is below management’s estimates or is generated in tax jurisdictions different than projected, the Company could be required to increase the valuation allowance for deferred tax assets. This would result in an increase in the Company’s effective tax rate.

### Net (Loss) Income

As a result of the foregoing, for the three months ended September 30, 2023, we recorded a net loss of $528,333, or $0.06 per share basic and fully diluted, compared with a net income of $390,944, or $0.05 per share (basic) and $0.04 per share (fully diluted) for the three months ended September 30, 2022.

### Six Months Ended September 30, 2023 and 2022

The following table presents net sales, cost of sales and gross profit, consolidated and by reportable segment:

*(dollars in thousands)*

| ​ ​ ​ Net sales | ​ ​ ​ | ​ ​ September 30, 2023 ​ ​ Amount ​ | ​ ​ ​ Percent of ​ ​ Net sales ​ | ​ ​ ​ ​ ​ September 30, 2022 ​ ​ ​ Percent of Amount ​ Net sales ​ ​ | ​ ​ Changes ​ ​ Amount ​ | ​ ​ ​ ​ ​ ​ ​ Percent ​ |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Ranor | ​ | $8,995 | 59% | $9,660 62% | $(665) | (7)% |
| Stadco | ​ | 6,573 | 43% | 5,939 38% | 634 | 11% |
| Intersegment elimination | ​ | (227) | (2)% | —% | (227) | nm% |
| Consolidated Net sales | ​ | $15,341 | 100% | $15,599 100% | $(258) | (2)% |
| **Cost of sales** | ​ |  | ​ | ​ |  |  |
| Ranor | ​ | $6,443 | 42% | $5,793 37% | $650 | 11% |
| Stadco | ​ | 7,169 | 46% | 7,249 47% | (80) | (1)% |
| Consolidated Cost of sales | ​ | $13,612 | 88% | $13,042 84% | $570 | 4% |
| **Gross profit (loss)** | ​ |  | ​ | ​ |  |  |
| Ranor | ​ | $2,325 | 15% | $3,867 24% | $(1,542) | (39)% |
| Stadco | ​ | (596) | (4)% | (1,310) (8)% | 714 | 55% |
| Consolidated Gross profit | ​ | $1,729 | 11% | $2,557 16% | $(828) | (32)% |

#### nm – not meaningful

### Net Sales

*Consolidated* - Period-to-period revenues reflect production performance under new and ongoing contracts with changes in net sales due to varying production activity levels. For the six months ended September 30, 2023, almost 100% of our sales were to the defense sector, where we have customers in the aerospace, military and shipbuilding industries.

Consolidated net sales were $15.3 million for the six months ended September 30, 2023, or 2% lower when compared to consolidated net sales of $15.6 million for the six months ended September 30, 2022. Net sales decreased by $0.7 million at Ranor offset in part by an increase $0.4 million at Stadco. Both segments logged a different proportionate mix of products for the comparable periods.

*Ranor –* Net sales were $8.9 million for the six months ended September 30, 2023, a decrease of $0.7 million or 7% lower when compared to the same prior-year period. Almost all of our net sales (99%) in the first six months of fiscal 2024 were in the defense sector. In the six months ended September 30, 2023, we had a different mix of products for U.S. Navy submarine projects, and experienced supply chain impacts on customer furnished material. We recorded a $1.0 million decrease when compared to the same period last year. The decrease was offset in part by a revenue increase of $0.3 million for a non-submarine customer. The backlog at Ranor on September 30, 2023 was $19.1 million.

*Stadco* - Net sales were $6.3 million for the six months ended September 30, 2023 compared with net sales of $5.9 million for the six months ended September 30, 2022, an increase of $0.4 million, or 8%. We continue to make better progress on projects where revenue is recognized over time. An increase in net sales for heavy lift helicopter and certain military products of $2.3 million offset a decrease of $1.9 million from aerospace and other military customers. Stadco’s backlog was $25.5 million as of September 30, 2023.

### Cost of Sales and Gross Profit

*Consolidated* - Cost of sales consists primarily of raw materials, parts, labor, overhead and subcontracting costs. Our cost of sales for the six months ended September 30, 2023, was $13.6 million, or 4% higher when compared to the six months ended September 30, 2022. The project mix changes discussed above also affected gross profit. Gross profit decreased by $0.8 million, or 32% when compared to the same period a year ago. Gross margin for the six months ended September 30, 2023 was 11.3% compared to 16.4% in the same period a year ago.

*Ranor –* Gross profit decreased by $1.5 million or 39% due primarily to a project mix with lower revenue and margins. We also realized fewer direct labor hours in the first six months of fiscal 2024. As such, factory overhead applied to our work-in-progress for the six months ended September 30, 2023 was lower than the overhead applied for the six months ended September 30, 2022.

*Stadco* - Gross margin was slightly negative for the six months ended September 30, 2023, as our losses decreased when compared to the six months ended September 30, 2022. Production problems related to equipment down-time were resolved in the first quarter of fiscal 2024. With a more favorable project mix, losses at Stadco decreased year over year on improved project margins, but not enough to overcome an increase in under-absorbed factory overhead. Revenue must continue to grow to enable improvement in gross profit and gross margin.

### Selling, General and Administrative (SG&A) Expenses

*(dollars in thousands)*

| ​ ​ ​ | ​ ​ | ​ ​ September 30, 2023 ​ ​ Amount | ​ ​ ​ ​ Percent of ​ Net Sales | ​ ​ September 30, 2022 ​ ​ Amount | ​ ​ ​ ​ ​ Percent of ​ Net Sales | ​ ​ Changes ​ ​ Amount | ​ ​ ​ ​ ​ Percent |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Ranor | ​ | $778 | 5% | $873 | 6% | $(95) | (11)% |
| Stadco | ​ | 631 | 4% | 904 | 6% | (273) | (30)% |
| Corporate and unallocated | ​ | 1,497 | 10% | 1,425 | 9% | 72 | 5% |
| Consolidated SG&A | ​ | $2,906 | 19% | $3,202 | 21% | $(296) | (9)% |

*September 30, 2022 SG&A segment data is revised to reflect current period updates to unallocated corporate administrative expense.*

*Consolidated* - Total selling, general and administrative expenses for the six months ended September 30, 2023 decreased by approximately $296,000, or 9% due primarily to lower expenses for compensation and office costs because of staff reductions.

*Ranor –* A decrease in outside advisory fees and office costs of $108,000 was offset in part by an increase in compensation and payroll taxes of approximately $13,000 for the comparable six-month periods. The prior year six-month period includes a one-time fee for services rendered in connection with securing the Employee Retention Tax Credit refund.

*Stadco* - SG&A expense for the six months ended September 30, 2023, decreased by approximately $273,000. The SG&A expenses for compensation and office costs decreased by approximately $271,000 because of staff reductions.

*Corporate and unallocated* - SG&A increased by approximately $72,000, due primarily to increased expenditures for insurance, outside services for software upgrades, and business taxes, offset in part by a decrease in stock-based compensation.

### Operating (loss) income

*(dollars in thousands)*

| ​ ​ ​ | ​ ​ ​ | ​ ​ September 30, 2023 ​ ​ Amount | ​ ​ ​ ​ ​ Percent of ​ net sales | ​ ​ September 30, 2022 ​ ​ Amount | ​ ​ ​ ​ ​ Percent of ​ net sales | ​ ​ Changes ​ ​ Amount | ​ ​ ​ ​ ​ Percent |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Ranor | ​ | $1,547 | 10% | $2,994 | 19% | $(1,447) | 48% |
| Stadco | ​ | (1,227) | (8)% | (2,214) | (14)% | 987 | (45)% |
| Corporate and unallocated | ​ | (1,497) | (10)% | (1,425) | (9)% | (72) | (5)% |
| Operating loss | ​ | $(1,177) | (8)% | $(645) | (4)% | $(532) | (82)% |

*Consolidated* - As a result of the foregoing, for the six months ended September 30, 2023, we reported an operating loss of $1.2 million, or $0.5 million higher than the operating loss for the six months ended September 30, 2022. Operating income at Ranor was not enough to offset the corporate expenses and operating losses at Stadco.

*Ranor –* Operating income was lower when compared to the same period a year ago, due primarily to lower revenue and higher cost of sales.

*Stadco –* Operating losses narrowed as certain projects with production issues, including equipment downtime, were resolved. Notwithstanding the better throughput, we recorded a smaller operating loss in the first six months of the 2024 fiscal year compared to the same period in the prior year.

*Corporate and unallocated –* Operating loss reflected the decrease in SG&A due primarily to a reduction in stock-based compensation offset in part by increased expenditures for insurance, outside services for software upgrades, and business taxes.

### Other Income (Expense), net

The following table presents other income (expense) for the six months ended:

| ​ ​ | ​ | ​ ​ September 30, 2023 | ​ | ​ ​ September 30, 2022 | ​ | ​ ​ $ Change | ​ ​ ​ % Change |
| --- | --- | ---: | --- | ---: | --- | ---: | ---: |
| Other income (expense), net | ​ | $40,876 | ​ | $40,336 | ​ | $540 | 1% |
| Interest expense | ​ | $(205,164) | ​ | $(140,628) | ​ | $(64,536) | (46)% |
| Amortization of debt issue costs | ​ | $(37,475) | ​ | $(26,747) | ​ | $(10,728) | (40)% |

Interest expense was higher when compared with the six months ended September 30, 2022 due primarily to higher amounts borrowed under the Revolver Loan (as defined below). Also, an increase in interest expense for the Ranor term loan, due to a higher interest rate assigned under the terms of the December 2022 renewal, offset by a decrease in interest expense for the Stadco term loan because of scheduled amortized maturity payments. Capitalized interest was also $14,455 higher when compared to the same period a year ago. We expect that future interest expense increases will likely correlate directly with borrowing levels under the Revolver Loan.

Amortization of debt issue costs for the six months ended September 30, 2023 was higher when compared to six months ended September 30, 2022. New amortization periods commenced in December 2022 for costs incurred to extend the Ranor Term Loan and renew the Revolver Loan.

Other income, net for the six months ended September 30, 2023 includes a gain from the sale of fixed assets. Other income, net, in the table above, for the six months ended September 30, 2022, includes income for the change in fair value for contingent consideration of $63,436 and other tax rebates for $33,223, offset in part by the fair value of the stock issued for $56,310 in connection with the Stadco acquisition.

### Income Taxes

For the six months ended September 30, 2023, the Company recorded a tax benefit $323,128, compared with a tax benefit of $38,205 for the six months ended September 30, 2022.

Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences and carryforwards are expected to be recovered or settled. The valuation allowance on deferred tax assets at September 30, 2023 was approximately $2.1 million. We believe that it is more likely than not that the benefit from certain state NOL carryforwards and other deferred tax assets will not be realized. In recognition of this risk, we continue to provide a valuation allowance on these items. In the event future taxable income is below management’s estimates or is generated in tax jurisdictions different than projected, the Company could be required to increase the valuation allowance for deferred tax assets. This would result in an increase in the Company’s effective tax rate.

### Net Loss

As a result of the foregoing, for the six months ended September 30, 2023, we recorded a net loss of $1.1 million, or $0.12 per share basic and fully diluted, compared with a net loss of $0.1 million, or $0.01 per share basic and fully diluted for the six months ended September 30, 2022.

### Liquidity and Capital Resources

Our liquidity is highly dependent on the availability of financing facilities and our ability to maintain a gross profit and operating income. For the six months ended September 30, 2023 we reported a net loss of $1.1 million.

As of September 30, 2023, we had $3.2 million in total available liquidity, consisting of $0.1 million in cash and cash equivalents, and approximately $3.1 million in undrawn capacity under our Revolver Loan. At of March 31, 2023, we had $4.7 million in total available liquidity, consisting of $0.5 million in cash and cash equivalents, and $4.2 million in undrawn capacity under our Revolver Loan.

The Company is the borrower under the amended and restated loan agreement with Berkshire Bank, or the “Loan Agreement”. There was $7.1 million outstanding under the agreement on September 30, 2023. The maturity date of the revolver loan under the loan agreement is December 20, 2023.

The Company was not in compliance with certain of the financial covenants at September 30, 2023 and has requested a waiver from Berkshire Bank, the lender, but has not yet received approval from the bank. Under the terms of the loan agreement, the bank has the right to demand repayment. If the lender demands repayment the Company will be unable to pay the obligation because the Company does not have existing facilities or sufficient cash on hand to satisfy these obligations. Also, it is probable that the Company will not be in compliance with the same debt covenants at subsequent measurement dates within the next twelve months. As such, all of our long-term debt has been classified as current in our condensed consolidated balance sheet.

Without a waiver, the lender has the right, but not the obligation, to demand repayment from the Company for noncompliance with the debt covenants. In addition, the bank retains the right to act on covenant violations that occur after the date of delivery of any waiver. If the lender were to decline to grant us a waiver and instead demand repayment, we would need to seek alternative financing to pay these obligations as the Company does not have existing facilities or sufficient cash on hand to satisfy these obligations.

The Company is exploring various means of strengthening its liquidity position and ensuring compliance with its debt financing covenants, which may include the obtaining of waivers from our current lender, amending our facility or entering into one or more alternative facilities.

In order for us to continue operations beyond the next twelve months from the date of issuance of the financial statements and to be able to discharge our liabilities and commitments in the normal course of business, we must mitigate our recurring operating losses at our Stadco subsidiary. We must efficiently increase utilization of our manufacturing capacity at our Stadco subsidiary and improve the manufacturing process, so our direct labor hours (inputs) allow us to recognize more revenue over time (outputs) and improve job performance. We plan to closely monitor our expenses and, if required, will reduce operating costs to enhance liquidity.

The uncertainty associated with the recurring operating losses at Stadco, the current violation of debt covenants, and expected debt covenant violation at subsequent compliance dates raise substantial doubt about our ability to continue as a going concern within one year after the date the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q are issued.

There was $1.9 million outstanding under the Revolver Loan at September 30, 2023, as the Company borrowed more at higher rates to finance working capital requirements. Interest paid and accrued under the Revolver Loan was $83,182 for the six months ended September 30, 2023. The weighted average interest rate at September 30, 2023 was 7.46%. At September 30, 2023 our working capital was negative because of the reclassification of our long-term debt from noncurrent to current in the condensed consolidated balance sheet. Working capital was $5.6 million at March 31, 2023.

The table below presents selected liquidity and capital measures at the fiscal years ended:

*(dollars in thousands)*

| ​ ​ | ​ ​ | ​ ​ September 30, 2023 | ​ ​ | ​ ​ March 31, 2023 | ​ ​ | ​ ​ Change Amount |
| --- | --- | ---: | --- | ---: | --- | ---: |
| Cash and cash equivalents | ​ | $138 | ​ | $534 | ​ | $(396) |
| Working capital | ​ | $(740) | ​ | $5,559 | ​ | $(6,299) |
| Total debt | ​ | $7,066 | ​ | $6,113 | ​ | $953 |
| Total stockholders’ equity | ​ | $13,514 | ​ | $14,594 | ​ | $(1,080) |

The next table summarizes changes in cash by primary component in the cash flows statements for the fiscal years ended:

*(dollars in thousands)*

| ​ ​ | ​ ​ | ​ ​ September 30, 2023 | ​ ​ | ​ ​ September 30, 2022 | ​ ​ | ​ ​ Change Amount |
| --- | --- | ---: | --- | ---: | --- | ---: |
| Operating activities | ​ | $1,258 | ​ | $1,623 | ​ | $(365) |
| Investing activities | ​ | (2,597) | ​ | ​ (1,073) | ​ | ​ (1,524) |
| Financing activities | ​ | 943 | ​ | ​ (1,367) | ​ | ​ 2,310 |
| Net decrease in cash | ​ | $(396) | ​ | $(817) | ​ | $421 |

#### Operating activities

Apart from our loan facilities, our primary sources of cash are from accounts receivable collections. Our customers make advance payments and progress payments under the terms of each manufacturing contract. The composition of our accounts receivable collections mix changes between advance payments and customer payments made after shipment of finished goods. Our cash flows can fluctuate significantly from period to period as we mark progress with customer projects and the timing of progress payments.

Cash provided by operating activities for the six months ended September 30, 2023 was approximately $1.3 million. In addition to customer progress payments, cash provided by operating activities included reimbursements under a certain customer project program. The sum of these customer payments was partially offset by payments for obligations for goods and services that had been acquired on open account from suppliers.

The six months ended September 30, 2022 was generally marked by favorable project performance progress and delivery schedules that led to timely customer payments. Cash provided by operating activities for the six months ended September 30, 2022 was $1.6 million, as customer cash advances and collections exceeded cash outflows on both new and older projects in-progress.

#### Investing activities

For the six months ended September 30, 2023, we invested $2.7 million in new factory machinery and equipment, primarily on the construction and installation of equipment for contract project work with a certain customer at our Ranor segment.

We are subject to certain financial debt covenants and may not spend more than $1.5 million for new machinery and equipment during any single fiscal year, tested on an annual basis at the end of each fiscal year.

We estimate our spending on new machinery and equipment in fiscal 2024, which we expect will include expenditures for the installation and construction of equipment for contract project work with a certain customer, will again exceed the spending limitation.

On June 12, 2023, we executed a waiver with the lender under which the lender agreed to waive the Company’s noncompliance with this capital spending limit covenant, as it relates to the period ended March 31, 2023. The waiver also contains an agreement by the parties to exclude from the calculation of capital expenditures for purposes of the Loan Agreement during the year ending March 31, 2024, any such expenditures made by the Company to the extent they are made using funds provided by customers of the Company for the purpose of making such capital expenditures.

We invested approximately $1.1 million in new factory machinery and equipment for the first six months of fiscal 2023.

#### Financing activities

For the six months ended September 30, 2023 we drew down $6.7 million of proceeds under the Revolver Loan and repaid $5.4 million during the same period. We also used approximately $307,000 of cash to pay down debt principal and make periodic lease payments.

We drew down $3.6 million of proceeds under our Revolver Loan during the six months ended September 30, 2022 and repaid $4.6 million during the same period. We also used approximately $336,000 of cash to make periodic lease payments and pay off certain lease and debt obligations.

All of the above activity resulted in a net decrease in cash of $396,268 for the six months ended September 30, 2023 compared with a net decrease in cash of $816,755 for the six months ended September 30, 2022.

#### Berkshire Bank Loans

On August 25, 2021, the Company entered into the Loan Agreement. Under the Loan Agreement, Berkshire Bank continues as lender of the Ranor Term Loan, as defined below, and the revolving line of credit, or the “Revolver Loan”. In addition, Berkshire Bank provided to Stadco a term loan in the original amount of $4.0 million, or the “Stadco Term Loan”. The proceeds of the original Ranor Term Loan of $2.85 million were previously used to refinance existing mortgage debt of Ranor. The proceeds of the Revolver Loan are used for working capital and general corporate purposes of the Company. The proceeds of the Stadco Term Loan were to be used to support the acquisition of Stadco and refinance existing indebtedness of Stadco.

On August 25, 2021, Stadco borrowed $4.0 million from Berkshire Bank under the Stadco Term Loan. Interest on the Stadco Term Loan is due on unpaid balances beginning on August 25, 2021, at a fixed rate per annum equal to the 7-year Federal Home Loan Bank of Boston Classic Advance Rate plus 2.25%. Since September 25, 2021, and on the 25th day of each month thereafter, Stadco has made and will continue to make monthly payments of principal and interest in the amount of $54,390 each, with all outstanding principal and accrued interest due and payable on August 25, 2028.

Payments for the original Ranor Term Loan began on January 20, 2017, and until the facility was amended in December 2022, the Company paid monthly installments of $19,260 each, inclusive of interest at a fixed rate of 5.21% per annum. Since the effectiveness of the most recent amendment in December 2022, the Company now makes monthly installment payments of $16,601 each, inclusive of interest at a fixed rate of 6.05% per annum. All outstanding principal and accrued interest is due and payable on the maturity date of December 15, 2027.

Under the Loan Agreement, Berkshire Bank also makes available to Ranor the Revolver Loan, which has a maximum principal amount available of $5.0 million. There was approximately $1.9 million and $650,000 outstanding under the Revolver Loan at September 30, 2023 and March 31, 2023, respectively. The maturity date of the Revolver Loan is December 20, 2023.

Under the amended promissory note for the Revolver Loan, the Company can elect to pay interest at the Term SOFR-based rate or an Adjusted Prime Rate, each determined and defined according to the terms of the agreement. The prior LIBOR-based rate expired on December 20, 2022.

The Ranor Term Loan, the Stadco Term Loan and the Revolver Loan, or collectively, the “Berkshire Loans,” may be accelerated upon the occurrence of an event of default as defined in the Loan Agreement. Upon the occurrence and during the continuance of certain default events, at the option of Berkshire Bank, or automatically without notice or any other action upon the occurrence of certain other events specified in the Loan Agreement, the unpaid principal amount outstanding under the facility, together with accrued interest and all other obligations, would become immediately due and payable without presentment, demand, protest, or further notice of any kind.

The Company agreed to maintain compliance with certain financial covenants under the Loan Agreement. Namely, the Company agreed to maintain a ratio of Cash Flow-to-Total Debt Service of not less than 1.20 to 1.00, measured quarterly on the last day of each fiscal quarter or annual period on a trailing 12-month basis. Calculations are based on the audited (year-end) and unaudited (quarterly) consolidated financial statements of the Company. Quarterly tests will be measured based on the financial statements included in the Company’s quarterly reports on Form 10-Q within 60 days of the end of each quarter, and annual tests will be measured based on the financial statements included in the Company’s annual reports on Form 10-K within 120 days after the end of each fiscal annual period. For purposes of the covenant, “Cash Flow” means an amount, without duplication, equal to the sum of net income of TechPrecision plus

(i) interest expense, plus (ii) taxes, plus (iii) depreciation and amortization, plus (iv) stock-based compensation expense taken by TechPrecision, plus (v) non-cash losses and charges and one time or non-recurring expenses at Berkshire Bank’s discretion, less (vi) the amount of cash distributions, if any, made to stockholders or owners of TechPrecision, less (vii) cash taxes paid by the TechPrecision, all as determined in accordance with U.S. GAAP. For purposes of the covenant, “Total Debt Service” means an amount, without duplication, equal to the sum of (i) all amounts of cash interest paid on liabilities, obligations and reserves of TechPrecision paid by TechPrecision, (ii) all amounts paid by TechPrecision in connection with current maturities of long-term debt and preferred dividends, and (iii) all payments on account of capitalized leases, all as determined in accordance with U.S. GAAP.

Additionally, the Company agreed to cause its Balance Sheet Leverage to be less than or equal 2.50 to 1.00. Compliance with this covenant is tested quarterly, as of the last day of each fiscal quarter. For purposes of the covenant, “Balance Sheet Leverage” means, at any date of determination, the ratio of the Company’s (a) Total Liabilities, less Subordinated Debt, to (b) Net Worth, plus Subordinated Debt. The Company also agreed that its combined annual capital expenditures will not exceed $1.5 million, subject to certain exclusions discussed below. Compliance is tested annually.

Finally, the Company agreed to maintain a Loan-to-Value Ratio of not greater than 0.75 to 1.00. For purposes of the covenant, “Loan-to-Value Ratio” means the ratio of (a) the sum of the outstanding balance of the Ranor Term Loan and the Stadco Term Loan to (b) the fair market value of the property pledged as collateral for the loan, as determined by an appraisal obtained from time to time by Berkshire Bank.

Collateral securing all the above obligations comprises all personal and real property of the Company, including cash, accounts receivable, inventories, equipment, and financial assets.

### Commitments and Contractual Obligations

The following contractual obligations associated with our normal business activities are expected to result in cash payments in future periods, and include the following material items on September 30, 2023:

- Our long-term debt obligations, including fixed and variable-rate debt, totaled $7.1 million, and, because of current and probable future debt covenant violations, are classified as current in the condensed consolidated balance sheets. Otherwise, except for $1.9 million due under the expiring revolver loan in December 2023, approximately $0.6 million is due annually for each of the next five years, plus a balloon payment of $2.0 million in December 2027.
- We enter into various commitments with suppliers for the purchase of raw materials and work supplies. Our outstanding unconditional contractual commitments, including for the purchase of raw materials and supplies goods, totaled approximately $3.3 million, all of it due to be paid within the next twelve months. These purchase commitments are in the normal course of business.
- Our lease obligations, including imputed interest, totaled $6.4 million for buildings through 2030, with approximately $0.9 million due annually for each of the next seven years.

There are no off-balance sheet arrangements as of September 30, 2023.

### EBITDA Non-GAAP Financial Measure

To complement our condensed consolidated statements of operations and condensed consolidated statements of cash flows, we use EBITDA, a non-GAAP financial measure. Net loss is the financial measure calculated and presented in accordance with U.S. GAAP that is most directly comparable to EBITDA. We believe EBITDA provides our board of directors, management, and investors with a helpful measure for comparing our operating performance with the performance of other companies that have different financing and capital structures or tax rates. We also believe that EBITDA is a measure frequently used by securities analysts, investors, and other interested parties in the evaluation of companies in our industry, and is a measure contained in our debt covenants. However, while we consider EBITDA to be an important measure of operating performance, EBITDA and other non-GAAP financial measures have limitations, and investors should not consider them in isolation or as a substitute for analysis of our results as reported under U.S. GAAP.

We define EBITDA as net loss plus interest, income taxes, depreciation, and amortization. Net loss was $0.5 million and $1.1 million for the three and six months ended September 30, 2023. EBITDA, a non-GAAP financial measure, was negative for the six months ended September 30, 2023. The following table provides a reconciliation of EBITDA to net income (loss), the most directly comparable U.S. GAAP measure reported in our consolidated financial statements for the three and six months ended:

*(dollars in thousands)*

| ​ ​ | ​ ​ | ​ ​ Three Months ended September 30, 2023 | ​ | ​ ​ 2022 | ​ | ​ ​ Change | ​ ​ | ​ ​ Six Months ended September 30, 2023 | ​ | ​ ​ 2022 | ​ | ​ ​ ​ Change |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net (loss) income | ​ | $(528) | ​ | $391 | ​ | $(919) | ​ | $(1,056) | ​ | $(110) | ​ | $(946) |
| Income tax (benefit) expense | ​ | ​ (177) | ​ | ​ 136 | ​ | ​ (313) | ​ | ​ (323) | ​ | ​ (38) | ​ | ​ (285) |
| Interest expense (1) | ​ | ​ 149 | ​ | ​ 84 | ​ | ​ 65 | ​ | ​ 243 | ​ | ​ 167 | ​ | ​ 75 |
| Depreciation and amortization | ​ | ​ 568 | ​ | ​ 532 | ​ | ​ 36 | ​ | ​ 1,128 | ​ | ​ 1,117 | ​ | ​ 11 |
| EBITDA | ​ | $12 | ​ | $1,143 | ​ | $(1,131) | ​ | $(8) | ​ | $1,136 | ​ | $(1,144) |

#### (1) Includes amortization of debt issue costs.

## Controls and procedures

As filed, 7,145 characters.

#### Evaluation of Disclosure Controls and Procedures.

Disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are controls and procedures that are designed to ensure that the information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and includes controls and procedures designed to ensure that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

As of the end of the period covered by this report, an evaluation was carried out, under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of September 30, 2023, our disclosure controls and procedures were not effective due to the material weaknesses in our internal control over financial reporting described below.

#### Inherent Limitations over Internal Controls

The Company’s internal control over financial reporting is designed under the supervision of our Chief Executive Officer and Chief Financial Officer, and effected by our board of directors, management, and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP. The Company’s internal control over financial reporting includes those policies and procedures that: (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the Company’s assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that the Company’s receipts and expenditures are being made only in accordance with authorizations of the Company’s management and directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

Management, including the Chief Executive Officer and Chief Financial Officer, does not expect that the Company’s internal controls will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of internal controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Also, any evaluation of the effectiveness of controls in future periods is subject to the risk that those internal controls may become inadequate because of changes in business conditions, or that the degree of compliance with the policies or procedures may deteriorate.

#### Material Weaknesses

We identified two material weaknesses in our internal control over financial reporting as of March 31, 2023, which still existed at September 30, 2023. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis. In connection with the preparation of our financial statements for the Annual Report on Form 10-K for the fiscal year ended March 31, 2023, management identified the following material weaknesses:

1\) we did not maintain proper controls, processes and procedures over the initial purchase accounting and the fair value accounting associated with our acquisition of Stadco that were adequately designed, documented, and executed to support the accurate and timely reporting of our financial results regarding the initial purchase accounting and the fair value accounting associated with the Stadco acquisition; and

2\) we did not maintain a sufficient complement of tax accounting personnel necessary to perform management review controls related to activities for extracting information to determine the valuation allowance at Stadco on a timely basis. Because of this material weakness, we made a late or post-closing adjustment to our valuation allowance while preparing the consolidated financial statements and footnotes included in the Annual Report on Form 10-K for the fiscal year ended March 31, 2023.

Notwithstanding the material weaknesses, management believes that the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q present fairly, in all material respects, the Company’s financial condition, results of operations and cash flows as of and for the periods presented in accordance with U.S. GAAP.

#### Management’s Remediation Plan

Our management, with the oversight of our audit committee, has initiated steps and plans to take additional measures to remediate the underlying causes of the material weaknesses, which we currently believe will be primarily through the development and implementation of new procedures, policies, processes, including revising the precision level of management review controls and gaining additional assurance regarding timely completion of our quality control procedures. It is possible that we may determine that additional remediation steps will be necessary in the future.

Our remediation plan will require that, going forward, management will utilize a valuation specialist with the requisite knowledge to perform all required valuations for all acquisitions of businesses, and utilize a tax specialist with the requisite knowledge to perform the required basic and detailed tax calculations so that all the parties can make a timely assessment of the Company’s tax provision.

The material weaknesses will not be considered remediated, however, until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively. We can provide no assurance as to when the remediation of these material weaknesses will be completed to provide for an effective control environment.

#### Changes in Internal Control over Financial Reporting

Except as disclosed under “Management’s Remediation Plan”, for the quarter ended September 30, 2023, there have been no changes in our internal control over financial reporting that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 4,614 characters.

We have listed below, as well as under the heading “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended March 31, 2023 (the “2023 Form 10-K”), supplemented by the disclosure below, a number of risks that may materially affect our business, financial condition or results of operations. You should carefully consider these Risk Factors and other information elsewhere in this Quarterly Report on Form 10-Q. These risks do not constitute all the risks that may be applicable to us. New risks may emerge from time to time, and it is not possible for us to predict all potential risks or to assess the likely impact of all risks.

***We are not currently in compliance with certain financial covenants under our loan agreement with Berkshire Bank and it is probable that we will not be in compliance within the next 12 months, which raises substantial doubt about our ability to continue as a going concern.***

Our liquidity is highly dependent on the availability of financing facilities and our ability to maintain a gross profit and operating income. The Company is the borrower under the amended and restated loan agreement with Berkshire Bank (the “Loan Agreement”). The Company has determined it is not in compliance with the financial covenants in the Loan Agreement as of September 30, 2023 and has requested a waiver from the lender. Additionally, our management believes it is probable that the Company will not be in compliance with these financial covenants in future periods. Without a waiver, noncompliance with these financial and related covenants permits the lender to demand repayment in full of all outstanding amounts from the Company. In addition, the lender retains the right to act on covenant violations that occur after the date of delivery of any waiver. If the lender were to demand repayment, the Company would not be able to pay the obligation because the Company does not have existing facilities or sufficient cash on hand to satisfy these obligations.

In order to satisfy the future financial covenants in the Loan Agreement, we must efficiently increase utilization of our manufacturing capacity at our Stadco subsidiary and improve the manufacturing process, such that our direct labor hours (inputs) allow us to recognize more revenue over time (outputs) and improve job performance. We plan to closely monitor our expenses and, if required, will reduce operating costs and capital spending to enhance liquidity. There can be no assurance that we will be successful in these efforts. If we are unable to achieve compliance in the future with the financial covenants in the Loan Agreement by making operational changes to our business, then we might alternatively seek additional waivers or forbearances from our lender prior to any covenant violation or raise additional funds in one or more equity financing transactions. Any covenant waiver or forbearance may lead to increased costs, increased interest rates, additional restrictive covenants and the imposition of other lender protections that impact us negatively. There can be no assurance that we would be able to obtain waivers or forbearances in a timely manner, on acceptable terms, or at all. Alternatively, the terms of any equity financing may adversely affect the holdings or the rights of our stockholders and the issuance of additional securities by us, or the possibility of such issuance, may cause the market price of our common stock to decline. The sale of additional shares of our common stock, or securities convertible into shares of our common stock, would also dilute all of our stockholders.

There was $7.1 million outstanding under the Loan Agreement on September 30, 2023. If we are unable to achieve compliance with the covenants in the Loan Agreement and unable to obtain a waiver or forbearance from our lender, any such default would allow the lender to accelerate this debt sooner than the applicable maturity dates. In the event that the lender accelerates the repayment of this indebtedness during the next 12 months as the result of one or more breaches of covenant, we do not expect to have funds available to repay these amounts in full, which raises substantial doubt about the Company’s ability to continue as a going concern within one year after the date the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q are issued. The consequences of any default, waiver or forbearance, or the securing of additional equity financing, could materially and adversely affect our business, financial condition, and results of operations.

Filed Nov 20, 2023.
Source: SEC EDGAR, the filing index for accession 0001410578-23-002556. Last ingested by Listed: Nov 10, 2026, 04:27 ET. No prices; not investment advice.
